MapLight Therapeutics, Inc. MPLT Noncash Lease Expense
Noncash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept mplt:NoncashLeaseExpense.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's noncash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's noncash lease expense?
- MapLight Therapeutics, Inc. (MPLT) reported noncash lease expense of $229K in Q1 2026.
- What does noncash lease expense mean?
- This represents the portion of lease expenses that does not involve an immediate cash outflow, typically associated with the amortization of right-of-use assets. It is added back to net income in the operating section of the cash flow statement to reconcile accounting expenses with cash-based operations. This metric helps isolate the impact of lease accounting standards on reported profitability.